Chemoendocrine therapy shows a greater negative association with patient-reported cognitive decline than endocrine therapy ...
From Base Power's $1B to NinjaOne's $500M, see Austin startups' biggest 2025 funding rounds, new valuations and who's backing ...
Rezdiffra FDA approval fuels sales; expansion to F4 MASH cirrhosis with 2027 trial data. Read more about MDGL stock here.
A district court judge in California over the holidays granted the National Labor Relations Board’s request to block a law ...
In the race against the "Carbon Cliff", AI is becoming an essential tool for balancing the economic equation. AI integration ...
As the war grinds on, sophisticated Russian defenses have pushed Ukraine to develop a frightening new weapon: semiautonomous ...
WisconsinEye needs to raise $250,000 (three months of its operating budget) to bridge a financial gap and allow state Capitol programming to resume.
A Vancouver Island University student has lost her appeal of a two-year suspension for her actions during protests for ...
Luddites" is pushing back against screen addiction and questioning whether more technology really means progress.
The order from the U.S. Court of Appeals for the Ninth Circuit is a win for Mr. Newsom, a Democrat, who has vigorously ...
Released every 12 to 18 months, 3D NAND scaling outpaces most other semiconductor devices in replacement rate and performance ...
India’s defence systems are changing in ways most people never notice. This fast growing company rests inside that change, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results